News

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII),…

1 year ago

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks…

1 year ago

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on…

1 year ago

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September

NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or…

1 year ago

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…

1 year ago

CBD of Denver, Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2024

Denver, Colorado--(Newsfile Corp. - August 30, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced its unaudited financial…

1 year ago

iZafe Group Q2 Interim Report, April-June 20234

STOCKHOLM, SE / ACCESSWIRE / August 30, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, August 30,…

1 year ago

Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update

RLF-TD011 investigator-initiated trial results for EB wound treatment anticipated in the coming weeksRLF-OD032 pilot PK study progresses with potential NDA…

1 year ago

Glioblastoma Foundation Genomic Testing & Research Laboratory Ribbon-Cutting Ceremony on Sept. 3rd

Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma diagnosis from terminal to treatableDURHAM,…

1 year ago

NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement

Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading…

1 year ago